スマートピル市場 – 2030年までの世界予測

出版社 MarketsandMarkets
出版年月 2025年3月

Smart Pills Market – Global Forecast To 2030

スマートピル市場 – 用途（カプセル内視鏡、薬物送達、患者モニタリング）、対象領域（食道、小腸、大腸、胃）、エンドユーザー（病院、診断センター）、地域別 – 2030年までの世界予測
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region – Global Forecast to 2030

The global smart pills market is experiencing significant growth in 2024, driven by the technological advancements in capsule endoscopy and the growing demand for non-invasive diagnostic monitoring devices. The market is projected to reach reach USD 1.30 billion by 2030 from USD 0.69 billion in 2024, at a CAGR of 11.2% during the forecast period.

世界のスマートピル市場は、カプセル内視鏡の技術的進歩と非侵襲性診断モニタリング機器の需要増加により、2024年に大幅な成長を遂げる見込みです。市場は、予測期間中に11.2%のCAGRで成長し、2024年の6億9,000万米ドルから2030年には13億米ドルに達すると予測されています。

According to the American Cancer Society (ACS), in 2024, there were 1,52,810 new cases of colorectal cancer (CRC) comprising, 81,540 will be in men and 71,270 in women. Additionally, 1,06,590 of the cases will be colon cancer, while 46,220 will be rectal cancer. CRC remains the second leading cause of cancer-related deaths in the US with an estimated 53,010 deaths in 2024, showing a slight increase from last year’s projected 52,550. Thus, the high incidence of colon cancer are expected to increase the demand for capsule endoscopes for colon cancer screening.

アメリカがん協会（ACS）によると、2024年には大腸がん（CRC）の新規症例が152,810件発生し、そのうち81,540件が男性、71,270件が女性となる見込みです。また、症例のうち106,590件が結腸がん、46,220件が直腸がんとなります。CRCは米国におけるがん関連死の第2位の原因であり、2024年には53,010人が死亡すると推定され、昨年の予測52,550人からわずかに増加しています。したがって、結腸がんの発生率が高いことから、結腸がん検査用のカプセル内視鏡の需要が高まると予想されます。

スマートピル市場 – 2030年までの世界予測
smart-pill-technology-market-Ecosystem

Key players in the Smart pills market

The key players operating in the smart pills market include Medtronic  (US), Olympus Corporation (Japan), CapsoVision,Inc. (US), IntroMedic (South Korea), ANX Robotics (US), Shenzhen Jifu Medical Technology Co., Ltd. (China), JINSHAN Science & Technology (Group)   (China), etectrx (US), Check-Cap (Israel), BodyCap (France) ,and Shangxian Minimal Invasive Inc (China).

This report provides insights into the following pointers:

  • Analysis of key drivers (rising demand for noninvasive diagnostic monitoring devices, technological advancements in capsule endoscopy, increasing incidence of colon cancer), restraints (high costs & technical limitations associated with accuracy of smart pills), opportunities (continuous innovation in sensor technology, wireless communication and rising need for rapid drug delivery development) and challenges (patient privacy concerns, shortage of skilled personnel).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the smart pills market
  • Market Development: Comprehensive information about lucrative markets – the report analyses the smart pills market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the smart pills market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of Medtronic (US), Olympus Corporation (Japan), CapsoVision,Inc. (US), IntroMedic (South Korea), ANX Robotics (US), Shenzhen jifu Medical Technology Co., Ltd. (China), JINSHAN Science & Technology (Group)   (China), etectrx (US), Check-Cap (Israel), BodyCap (France) , and Shangxian Minimal Invasive Inc (China) in the smart pills market.